⌘K
Loading ticker…
Processa Pharmaceuticals, Inc. Common · Healthcare · Pharmaceutical Products
As of 2026-06-26, Processa Pharmaceuticals, Inc. Common (PCSA) has a 3-month relative strength percentile of 19 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 12.5%, relative volume 0.35×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
19 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PCSA is in a stage 4 downtrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -27.4% / -56.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PCSA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $32K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $32K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PCSA Jan avg: -27.32% median: -24.36% win: 25% σ: 28.39% n: 4 2022-04-12 → 2026-05-29 | PCSA Feb avg: -15.15% median: -18.59% win: 25% σ: 13.84% n: 4 2022-04-12 → 2026-05-29 | PCSA Mar avg: -11.36% median: -14.60% win: 25% σ: 22.15% n: 4 2022-04-12 → 2026-05-29 | PCSA Apr avg: -3.46% median: -7.82% win: 40% σ: 21.15% n: 5 2022-04-12 → 2026-05-29 | PCSA May avg: -6.67% median: -5.18% win: 20% σ: 16.45% n: 5 2022-04-12 → 2026-05-29 | PCSA Jun avg: 2.97% median: -4.78% win: 50% σ: 36.47% n: 4 2022-04-12 → 2026-05-29 (current) | PCSA Jul avg: -1.25% median: -1.88% win: 50% σ: 9.64% n: 4 2022-04-12 → 2026-05-29 | PCSA Aug avg: -21.06% median: -19.96% win: 0% σ: 12.24% n: 4 2022-04-12 → 2026-05-29 | PCSA Sep avg: -9.33% median: -9.27% win: 25% σ: 11.33% n: 4 2022-04-12 → 2026-05-29 | PCSA Oct avg: 30.28% median: 17.05% win: 50% σ: 54.13% n: 4 2022-04-12 → 2026-05-29 | PCSA Nov avg: 9.64% median: -5.17% win: 50% σ: 50.44% n: 4 2022-04-12 → 2026-05-29 | PCSA Dec avg: -42.21% median: -44.90% win: 0% σ: 13.62% n: 4 2022-04-12 → 2026-05-29 |